Both in Biotechnology
Compass Therapeutics vs enGene Therapeutics
Over the past year CMPX returned −79.9% and ENGN returned −73.7%; their daily moves had a correlation of 0.10.
CMPX −79.9% ENGN −73.7%Growth of $1, one year, split-adjusted
| Metric | CMPX | ENGN |
|---|---|---|
| Price | $0.7627 | $1.72 |
| Market cap | $137.4M | $115.3M |
| Today | +1.29% | +6.17% |
| 1 month | −23.6% | −4.4% |
| 6 months | −59.2% | −80.6% |
| Year to date | −85.8% | −81.0% |
| 1 year | −79.6% | −75.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $179.9M | $241.0M |
| Dividend yield | — | — |
| Volatility (60d) | 100.5% | 58.2% |
| Short % of float | 33.9% | 3.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).